TipRanks
Advertisement
Advertisement
Analyst Jill Wu Raises Target Price and Reiterates Buy on Innovent Biologics After Strong 1H26 Beat and Robust Growth Outlook
PremiumRatingsAnalyst Jill Wu Raises Target Price and Reiterates Buy on Innovent Biologics After Strong 1H26 Beat and Robust Growth Outlook
1M ago
Jack Lin Reiterates Buy on Innovent Biologics, Citing Strong Profitability, Solid Revenue Growth, and De-Risked Late-Stage Pipeline
Premium
Ratings
Jack Lin Reiterates Buy on Innovent Biologics, Citing Strong Profitability, Solid Revenue Growth, and De-Risked Late-Stage Pipeline
1M ago
Innovent Biologics Reshapes Board Roles as Veteran Executive Retires from Full-Time Post
Premium
Company Announcements
Innovent Biologics Reshapes Board Roles as Veteran Executive Retires from Full-Time Post
1M ago
Spero Therapeutics, Innovent Biologics enter license agreement for SP001
PremiumThe FlySpero Therapeutics, Innovent Biologics enter license agreement for SP001
3M ago
Innovent Biologics, Eli Lilly enters Verzen distribution and promotion agreement
Premium
The Fly
Innovent Biologics, Eli Lilly enters Verzen distribution and promotion agreement
3M ago
Innovent Biologics Shareholders Approve All AGM Resolutions, Strengthening Capital Flexibility
Premium
Company Announcements
Innovent Biologics Shareholders Approve All AGM Resolutions, Strengthening Capital Flexibility
3M ago
Innovent Biologics Sets June 2026 AGM With Share Buyback and Issuance Mandates on Agenda
PremiumCompany AnnouncementsInnovent Biologics Sets June 2026 AGM With Share Buyback and Issuance Mandates on Agenda
4M ago
Innovent Strikes Up to US$10.5 Billion Global Oncology Pact With Pfizer
Premium
Company Announcements
Innovent Strikes Up to US$10.5 Billion Global Oncology Pact With Pfizer
4M ago
Pfizer enters into global strategic collaboration with Innovent Biologics
Premium
The Fly
Pfizer enters into global strategic collaboration with Innovent Biologics
4M ago

Trending

Name
Price
Price Change
S&P 500
―
Dow Jones
―
Nasdaq 100
―